In 2019, Black Legend Capital acted as a consulting advisor in the capital structure efforts to a U.S. publicly traded holding company, known as TRICCAR. The Las Vegas based company is vertically integrated in both canna nutraceutical and bioceuticals spaces. TRICCAR makes clinically tested and proven bioceutical products for obesity, diabetic nerve pain, calcium deficiency, hypothyroidism, menopause markets, and holds a formula that showed promise in reversing the effects of ALS (Lou Gehrig’s disease). At the time of the transaction, they were in discussions with Meridian Medical Practice Solutions (which provides practice services for more than 60,000 physicians and chiropractors) to allow doctors and their patients access to TRICCAR products through the physician groups’ websites.
